Kuk Hyoun Hwang - Feb 21, 2023 Form 4 Insider Report for Bellevue Life Sciences Acquisition Corp. (BLAC)

Role
Chief Executive Officer, Director, 10%+ Owner
Signature
/s/ Kuk Hyoun Hwang
Stock symbol
BLAC
Transactions as of
Feb 21, 2023
Transactions value $
$0
Form type
4
Date filed
2/23/2023, 03:31 PM
Previous filing
Feb 16, 2023
Next filing
Mar 27, 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BLAC Common Stock Other $0 +225K +12.5% $0.00 2.03M Feb 21, 2023 By Bellevue Global Life Sciences Investors LLC F1, F2
transaction BLAC Common Stock Other $0 -4.5K -0.22% $0.00 2.02M Feb 21, 2023 By Bellevue Global Life Sciences Investors LLC F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of common stock held by Bellevue Global Life Sciences Investors LLC the sponsor of the Issuer (the "Sponsor"), whose general partner is Bellevue Capital Management LLC ("Bellevue Capital"). Kuk Hyoun Hwang is the managing partner of Bellevue Capital and has voting and dispositive power over the shares held by the Sponsor.
F2 Represents the shares that will no longer be forfeited by the Sponsor as a result of the underwriters exercising the over-allotment option in full.
F3 Represents an additional 4,500 shares that were transferred from the Sponsor to the underwriters as a result of the underwriters exercising the over-allotment option in full.